Misgav M, et al.
Journal of Pediatric Hematology/Oncology 2013: 00:000-000
This study reports findings on 6 bleeding episodes on 5 patients (median age 2 y) with severe bleeding disorders were treated with topical HemCon chitosan-based dressing. The dressing was used either after the failure of extensive systemic therapy or as the first choice of treatment. In 4 of the 6 episodes, bleeding ceased immediately alleviating the need for systemic therapy. There was no rebleeding after the removal of the dressing and no adverse events or local skin reactions were recorded, indicating that hemostatic dressings, such as the chitosan, should be encouraged for the treatment of external/accessible bleeds, especially among the pediatric patients with bleeding tendency.Link to Study